Scholars Central

Conference abstractPublished 1 Mar 2018

Structural modification and bioactivity evaluation of multi-targeted Tetrahydroprotoberberine Derivatives (THPBs)

Authors: Hong Liu, Yu Zhou

Shanghai Institute of Materia Medica-CAS, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tetrahydroprotoberberines (THPBs) belong to a class of tetrahydroisoquinoline alkaloids with multiple bioactivities derived mainly from Chinese medicinal herbs. In the 1960, tetrahydropalmatine (THP) and its analogs were tested as new types of central depressants. Subsequent investigations focused on the effect of THP on the dopaminergic system. An effective and rapid method for the microwave-assisted preparation of the key intermediate for the total synthesis of THPBs including l-stepholidine (l-SPD) was developed. A series of new THPB derivatives were designed, synthesized, and tested for their binding affinity towards dopamine (D1 and D2) and serotonin (5-HT1A and 5-HT2A) receptors. Many of the THPB compounds exhibited high binding affinity and activity at the dopamine D1 receptor, as well as high selectivity for the D1 receptor over the D2, 5-HT1A, and 5-HT2A receptors. On the basis of the pharmacophore model of the marketed drug silodosin, THPBs were modified by introducing an indole segment into their core scaffolds. In calcium assays, 7 compounds displayed excellent antagonistic activities against Ã?±1A-ARs, with IC50 less than 250 nM. In the functional assay using isolated rat tissues, compound (S)-27 inhibited norepinephrine induced urethra smooth muscle contraction potently, without inhibiting the aortic contraction, displaying a better tissue selectivity than the marketed drug silodosin. Additional results of preliminary safety studies and pharmacokinetics studies indicated the potential druggability for compound (S)-27 which is a promising lead for the development of selective Ã?±1A-AR antagonists for the treatment of benign prostatic hyperplasia (BPH). Recent publications 1. Guo D, Li J, Lin H, Zhou Y, Chen Y, et al. (2016) Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as selective Ã?±1A-adrenoceptor antagonists. J Med Chem 59:9489-9502. 2. Zhou S, Duan Y, Wang J, Zhang J, Sun H, et al. (2017) Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes. Eur J Med Chem 140:448-464 3. Li Z, Huang J, Sun H, Zhou S, Guo L, et al. (2014) Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Bioorg Med Chem 22:5838-5846.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Organic Chemistry: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOrganic Chemistry: Current Research
  • SubjectChemistry
  • BylineArticles whose byline prints “Hong Liu”
  • BylineArticles whose byline prints “Yu Zhou”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels